Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving nucleic acid
Patent
1998-05-15
1999-09-14
Feisee, Lila
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
Involving nucleic acid
536 231, 536 235, 530324, 530300, C12Q 168, C12N 1510, C12N 1512, C07K 1482
Patent
active
059521791
ABSTRACT:
A domain of Bcl-2 that suppresses apoptosis by allowing cell survival permits cell proliferation when mutated. The wild type domain includes amino acid residues 51 to 97 (SEQ ID NO: 13) of Bcl-2. Peptides including the domain and nucleotides encoding the domain are useful in molecular screening of human tumors for the presence of mutations that allow proliferation of cells that were otherwise marked for apoptosis. The peptides are also useful to screen for proteins that play a role in the modulation of cellular proliferation.
REFERENCES:
Z. Songyang et al., "SH2 Domains Recognize Specific Phosphopeptide Sequences", Cell, 72:767-778 (1993).
J. Saras et al., "Characterization of the Interactions between PDZ Domains of the Protein-tyrosine Phosphatase PTPL1 and the Carboxyl-terminal Tail of Fas", J. Bio. Chem., 272:20979-20981 (1997).
Feisee Lila
Kaufman Claire M.
St. Louis University Health Sciences Center
LandOfFree
Screens for mutations in the anti-proliferation domain of human does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Screens for mutations in the anti-proliferation domain of human , we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Screens for mutations in the anti-proliferation domain of human will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1509133